UNSPSC 85818701: Transfusion of autologous antihemophilic factors into central artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous antihemophilic factors into central artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30263V0

UNSPSC 85818701 Transfusion of autologous antihemophilic factors into central artery, percutaneous approach is a Commodity code that does not align with actual state and local procurement activity recently posted under this classification. The code's nominal scope—a clinical medical procedure involving factor transfusion—bears no relationship to the six recent opportunities tagged under it. Those solicitations instead seek independent medical evaluation services, surgical benefit carve-outs for employee health plans, occupational medical surveillance, emergency and specialty care for detained youth, pharmacy benefit management administration, and temporary health professional staffing. None of these services involve autologous antihemophilic factor administration or any transfusion procedure. The mismatch suggests either systematic miscoding of these opportunities by the issuing bodies or a data classification error that renders the code itself unreliable as a signal for relevant procurement activity.

The recent opportunities span retirement boards (City of Phoenix), municipal employee benefits (City of Long Beach, Collier County), state transportation agencies (Washington State Department of Transportation), county juvenile justice systems (Harris County), and county health systems (Santa Clara County Health System). Geographic activity appears concentrated in Arizona, California, Florida, and Washington, with solicitations due between September and October 2026. None of the six opportunities present an actionable signal for firms pursuing work under this code's stated medical scope.